EP3133070
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.11.2010:
14.8.2019:
16175117.7
:
23.11.2030
:
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT
24.11.2010
14.8.2019
:
Genzyme Corporation:
50 Binney Street, 02142, Cambridge, MA, US
:
LIU, Hanlan:
Lexington, MA, US
:
WILLIS, Chris:
Southborough, MA, US
:
BHARDWAJ, Renu:
Ashland, MA, US
:
COPELAND, Diane P.:
Billerica, MA, US
:
HARIANAWALA, Abizer:
Acton, MA, US
:
SKELL, Jeffrey:
Westborough, MA, US
:
MARSHALL, John:
Bridgewater, NJ, US
:
KOCHLING, Jianmei:
Wellesley, MA, US
:
PALACE, Gerard:
Framingham, MA, US
:
PETERSCHMITT, Judith:
Watertown, MA, US
:
SIEGEL, Craig:
Woburn, MA, US
:
CHENG, Seng:
Natick, MA, US
:
264748 P:
27.11.2009:
US
:
C07D 405/06, A61K 45/06, A61K 31/4025, A61P 35/00